Diabetes Care, Vol 21, Issue 4 535-538, Copyright © 1998 by American Diabetes Association

ARTICLES

The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM

AE Gold, R Reilly, J Little and JD Walker
Department of Diabetes, Royal Infirmary, Edinburgh, Scotland, U.K.

OBJECTIVE: To examine data from pregnancies in women with IDDM to assess the relative effects of mean glycosylated hemoglobin levels before conception, at booking, and during the 3 trimesters of pregnancy on birth weight. Good glycemic control during pregnancy in women with IDDM is important to minimize the risk of fetal malformation and macrosomia. Recent studies have suggested that glycemic control in the 1st trimester is more important than glycemic control during the 2nd or 3rd trimesters. RESEARCH DESIGN AND METHODS: The case records of 65 deliveries to women with IDDM were reviewed. Fifty-seven deliveries were included in the present study. Of the deliveries reviewed, 32 women were in their first pregnancy and 25 women were multiparous. Only viable pregnancies were included because the major outcome variable of interest was birth weight. Glycosylated hemoglobin was recorded for each time period. RESULTS: The median standardized birth weight was 1.1 SD higher than the nondiabetic mean. When pregnancies, in which the birth weight was greater than 1 SD above the nondiabetic mean, were compared with pregnancies, in which birth weight was less than 1 SD above the mean, significant differences were observed between the groups in HbA1 at 6-12 months pre-conception (10.0 +/- 2.3 vs. 8.6 +/- 1.4%, P = 0.02), at 0-6 months pre-conception (10.2 +/- 2.4 vs. 8.7 +/- 2.0%, P = 0.03), at booking (9.5 +/- 2.2 vs. 8.4 +/- 1.6%, P = 0.04), and at 0-12 weeks' gestation (9.5 +/- 2.2 vs. 8.0 +/- 1.3%, P = 0.04), but HbA1 later in pregnancy did not differ significantly between the groups. Correlational analysis of all 57 pregnancies revealed significant correlations between birth weight and HbA1 at 0-6 months pre-conception (r = 0.44, P = 0.002), at booking (r = 0.43, P = 0.001), at 0-12 weeks' gestation (r = 0.48, P = 0.001), at 12-24 weeks' gestation (r = 0.45, P = 0.001), and at 24 weeks to term (r = 0.34, P = 0.009). However, with stepwise regression analysis, only HbA1 at 0-12 weeks' gestation entered into the equation with a multiple r value of 0.48. CONCLUSIONS: Glycemic control in the immediate pre-conception period and early 1st trimester appears to have a greater influence on birth weight than does glycemic control during the later weeks of pregnancy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Pfab, T. Slowinski, M. Godes, H. Halle, F. Priem;, and B. Hocher Low Birth Weight, a Risk Factor for Cardiovascular Diseases in Later Life, Is Already Associated With Elevated Fetal Glycosylated Hemoglobin at Birth Circulation, October 17, 2006; 114(16): 1687 - 1692. [Abstract] [Full Text] [PDF]

				R. C. Temple, V. J. Aldridge, and H. R. Murphy Prepregnancy Care and Pregnancy Outcomes in Women With Type 1 Diabetes Diabetes Care, August 1, 2006; 29(8): 1744 - 1749. [Abstract] [Full Text] [PDF]

				J. S. Haas, E. Fuentes-Afflick, A. L. Stewart, R. A. Jackson, M. L. Dean, P. Brawarsky, and G. J. Escobar Prepregnancy Health Status and the Risk of Preterm Delivery Arch Pediatr Adolesc Med, January 1, 2005; 159(1): 58 - 63. [Abstract] [Full Text] [PDF]

				S. F. Wong, F. Y. Chan, J. J.N. Oats, and D. H. McIntyre Fetal Growth Spurt and Pregestational Diabetic Pregnancy Diabetes Care, October 1, 2002; 25(10): 1681 - 1684. [Abstract] [Full Text] [PDF]

				J.G. Ray, T.E. O'brien, and W.S. Chan Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis QJM, August 1, 2001; 94(8): 435 - 444. [Abstract] [Full Text] [PDF]